Genextra Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 5
Professionals
  • Investments
  • 11
  • Portfolio
  • 7
  • Exits
  • 4
Exits

Genextra General Information

Description

Founded in 2004, Genextra is a venture capital firm based in Milan, Italy. The firm seeks to invest in early-stage life science companies.

Contact Information

Website
Year Founded
2004
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
  • Via Privata Giovannino De Grassi, 11
  • 20123 Milan
  • Italy
+39 02 0000 0000

Genextra Investments (11)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
InnovHeart 30-Jul-2020 Later Stage VC 000.00 Surgical Devices Generating Revenue 00000000 000000 00.0
0000000000 0000000 14-Jul-2020 00000 00000 00.000 Drug Discovery Generating Revenue 00000 000000ò
00000 000000000 12-Sep-2019 00000 00000 00.000 Drug Discovery Clinical Trials - Phase 2 00000000 000000 00.0
000000 24-Apr-2018 00000 00000 000.00 Diagnostic Equipment Generating Revenue 00000 000000ò
000000 11-May-2015 00000 00000 000.00 Diagnostic Equipment Generating Revenue 00000 000000ò
0000000000 01-Jan-2015 00000 00000 Surgical Devices Generating Revenue 00000 000000ò
000000000(00000000 09-Aug-2012 00000 00000 0000 Drug Discovery Generating Revenue/Not Profitable 0000000 000000000 00
000000000(00000000 25-Jan-2010 00000 00000 0000 Drug Discovery Generating Revenue/Not Profitable 0000000 000000000 00
Intercept(Biotechnology) 29-Jul-2008 Later Stage VC 0000 Drug Discovery Generating Revenue/Not Profitable 0000000 000000000 00
Congenia Buyout/LBO Drug Discovery Clinical Trials - Phase 1
You’re viewing 10 of 11 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Genextra Exits (4)

Company Name Exit Date Exit Type Exit Size
Intercept(Biotechnology) 09-Oct-2015 Secondary Transaction - Open Market
000000000(00000000 18-Jun-2013 000000 0000000000 000.00
Intercept(Biotechnology) 11-Oct-2012 IPO 0000
Intercept(Biotechnology) Secondary Transaction - Open Market
To view Genextra’s complete exits history, request access »

Genextra Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Genextra Team (4)

Name Title Deals Funds Boards Office
Paolo Fundarò Chief Executive Officer & Board Member 0 0 Milan, Italy
Francesco Micheli Founder and Executive Chairman 0 Milan, Italy
Daniele Scarinci Investment Director 0 0 Milan, Italy
Federica Draghi Ph.D Investment Director 0 0 Milan, Italy
To view Genextra’s complete team members history, request access »